Apple Archives - Page 3 of 3 - Medical Design Sourcing

Apple magnetic charger, smartwatch may deactivate Medtronic ICD

Apple iPhone 12 with MagSafe technology (Image from Apple)

A new study in the Heart Rhythm Journal showed a magnetic charger for the iPhone 12 was able to deactivate a Medtronic implantable cardioverter defibrillator (ICD).

The iPhone 12 has a circular array of magnets deployed around a central charging coil, making it compatible with the company’s wireless “MagSafe” accessories, according to the study published Jan. 4, 2021. In the study, approved by an Institutional Review Board, researchers brought an iPhone 12 close to a ICD patient’s left chest area and noted that ICD therapy immediately stopped. “This was reproduced multiple times with different positions of the phone over the pocket,” the authors wrote.

Get the full story on our sister site, Medical Design & Outsourcing.

Apple, Biogen partner on using smart devices to track cognitive health

Biogen (NSDQ:BIIB) today announced a virtual research study in collaboration with Apple (NSDQ:AAPL) for monitoring and screening cognitive health.

The multi-year, observational research study, set to be launched later this year, is slated to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for a decline in cognitive health, including mild cognitive impairment (MCI), according to a news release.

Cambridge, Mass.-based Biogen said the study will enroll participants, including young and aging adults, with a wide range of cognitive performance to achieve primary objectives including the development of digital biomarkers for monitoring cognitive performance over time and the identification of early signs of MCI.

“Cognitive decline can be an early symptom of neurodegenerative diseases and dementia. The successful development of digital biomarkers in brain health would help address the significant need to …

Apple, Biogen partner on using smart devices to track cognitive health

Biogen (NSDQ:BIIB) today announced a virtual research study in collaboration with Apple (NSDQ:AAPL) for monitoring and screening cognitive health.

The multi-year, observational research study, set to be launched later this year, is slated to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for a decline in cognitive health, including mild cognitive impairment (MCI), according to a news release.

Get the full story at our sister site, Medical Design & Outsourcing.

Zimmer Biomet updates remote care system used with Apple Watch

Zimmer Biomet (NYSE:ZBH) this week said it is creating a remote care management system with new MyMobility features on the Apple Watch.

The new features expand upon existing work between Apple and Zimmer Biomet, who launched the care management system in October 2018 to transform pre- and post-operative joint replacement experience.

MyMobility’s features Measure gait quality, and provide healthcare professionals with virtual touchpoints and real-time patient information to enhance decision-making. Patients will continue to receive a connected and customizable experience throughout their care.

Gait metrics are measured using sensors in the Apple watch and iPhone to collect walking speed and double support time while walking on flat-level surfaces, without using GPS. The features will be available to hip and knee joint replacement patients and their healthcare professionals through Zimmer Biomet’s digital platform later this year.

“Digit…